Global Hospital Acquired Infection Control Market Insights Forecasts to 2033

• The Global Hospital Acquired Infection Control Market Size was Valued at USD 4.1 Billion in 2023
• The Market Size is Growing at a CAGR of 3.53% from 2023 to 2033
• The Worldwide Hospital Acquired Infection Control Market Size is Expected to Reach USD 5.8 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Global Hospital Acquired Infection Control Market Size is Anticipated to Exceed USD 5.8 Billion by 2033, Growing at a CAGR of 3.53% from 2023 to 2033.

Market Overview

Hospital-acquired infection (HAI) Control refers to the strategies, procedures, and practices used in healthcare settings to prevent infections that patients may contract while receiving medical treatment. These infections, also known as nosocomial infections, can occur in hospitals, clinics, and other healthcare facilities and pose serious risks to patient health, frequently resulting in longer hospital stays, increased healthcare costs, and, in severe cases, death. Effective HAI control requires a combination of hygiene practices, including hand washing, medical equipment sterilization, and healthcare workers wearing personal protective equipment (PPE). It also includes measures such as isolating infected patients, using antibiotics properly to prevent the development of resistant bacteria, and following rigorous cleaning protocols. Infection control teams in hospitals monitor infection rates, train staff on best practices, and implement policies to reduce the risk of infection transmission. As healthcare-associated infections continue to be a major challenge in medicine, HAI control is critical for ensuring patient safety, improving outcomes, and maintaining overall healthcare quality.

Report Coverage

This research report categorizes the market for the global hospital acquired infection control market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global hospital acquired infection control market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global hospital acquired infection control market.

Driving Factors

Increasing the number of surgical procedures

The number of surgical procedures performed around the world has increased dramatically over time. According to the World Health Organization, approximately 235 million major surgical procedures are performed worldwide each year. This is due to the rising prevalence of obesity and other lifestyle diseases, a growing geriatric population, and an increase in spinal and sports-related injuries. The growing number of surgical procedures has increased the demand for various surgical equipment and medical devices. This is expected to drive demand for hospital-acquired infection services due to the proven benefits of sterilized products and rising awareness of their effectiveness in healthcare settings.

Restraining Factors

Concerns for the safety of reprocessed instruments

Concerns about inadequate cleaning and sterilization increase the risk of infections and poor patient outcomes, limiting acceptance among healthcare providers.

Market Segmentation

The global hospital acquired infection control market share is classified into type and end-user.

• The consumables segment is expected to hold the largest share of the global hospital acquired infection control market during the forecast period.   

Based on the type, the global hospital acquired infection control market is categorized into equipment, services, and consumables. Among these, the consumables segment is expected to hold the largest share of the global hospital acquired infection control market during the forecast period. The Consumables segment's strong performance is due to the high demand for single-use infection control products. These products are critical for preventing the spread of infections in healthcare settings. The consistent demand for disposables such as gloves, gowns, and masks, particularly in the aftermath of global health crises, has significantly contributed to the consumables segment's growth.

• The hospitals and intensive care units (ICUs) segment is expected to grow at the fastest CAGR during the forecast period.  

Based on the end-user, the global hospital acquired infection control market is categorized into hospitals and intensive care units (ICUs), ambulatory surgical, diagnostic centers, and others. Among these, the hospitals and intensive care units (ICUs) segment is expected to grow at the fastest CAGR during the forecast period. Hospital and intensive care unit (ICU) dominance is driven by the high infection risk in these settings and the urgent need for strict infection control measures. As key healthcare centers, hospitals and ICUs consistently need advanced infection control solutions to safeguard patient safety and prevent the spread of hospital-acquired infections.

Regional Segment Analysis of the Global Hospital Acquired Infection Control Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is projected to hold the largest share of the global hospital acquired infection control market over the forecast period.

North America is projected to hold the largest share of the global hospital acquired infection control market over the forecast period. This dominance is primarily due to the rising incidence of chronic diseases such as cancer and Crohn's disease, as well as an increase in hospital-acquired infections. Aging patients, prone to chronic illnesses, are more likely to contract hospital infections, necessitating increased infection control measures. The North America market is also driven by increased awareness of infection control protocols and healthcare spending. Developments in infection control technology, the use of personalized medicines, and cost-effective treatments for hospital-acquired infections all contribute to market growth.

Asia Pacific is expected to grow at the fastest CAGR growth of the global hospital acquired infection control market during the forecast period. This growth is driven by the growing incidence of hospital-acquired infections in emerging economies and the increased adoption of sterilization and disinfection equipment. The region's emphasis on R&D, healthcare reforms, and technological advancements in medical device manufacturing is vital. Also, the demand for medical nonwoven products and increased funding from the governmental and non-government sectors for infection control awareness drive market growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global hospital acquired infection control market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Olympus Corporation
• Getinge AB
• Xenex Disinfection Services
• 3M Company
• Sonoma Pharmaceuticals, Inc.
• Advanced Sterilization Products
• Stryker
• Belimed AG
• Becton
• Dickinson and Company
• Biomerieux Sa
• Cantel Medical
• Ethicon
• Kimberly-Clark Corporation
• Sterigenics International LLC
• Others

Key Market Developments

• In March 2023, Stryker launched SmartMedic, India's first ICU bed upgrade platform, to improve patient care and caregiver safety.

• In June 2022, Sonoma Pharmaceuticals, Inc. and the MicroSafe Group DMCC announced that Nanocyn, a hospital-grade disinfectant, has been added to the US Environmental Protection Agency's List N of COVID-19 disinfectants.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global hospital acquired infection control market based on the below-mentioned segments: 

Global Hospital Acquired Infection Control Market, By Type

• Equipment
• Services
• Consumables

Global Hospital Acquired Infection Control Market, By End-user

• Hospitals and Intensive Care Units (ICUs)
• Ambulatory Surgical
• Diagnostic Centers
• Others

Global Hospital Acquired Infection Control Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa